D.O.R.C. Limited

What D.O.R.C. Limited does

D.O.R.C. Limited (operating as DORC, Dutch Ophthalmic Research Center) is a Netherlands-headquartered medical device company that designs, manufactures, and distributes ophthalmic surgical equipment, instruments, and consumables for vitreoretinal, cataract, and corneal procedures. Its core technology is the EVA NEXUS surgical platform — an integrated system that anchors a portfolio of proprietary consumables including the TDC VELOCE next-generation high-speed vitrectomy cutter, EVA AVETA trocar cannula system, surgical dyes (VisionBlue trypan blue stain for cataract surgery and MEMBRANEBLUE-DUAL for ILM/ERM staining), SURGICON single-use ophthalmic knives, vitrectomy cutters, endoillumination, laser probes, microinjection, diathermy, microforceps, microscissors, backflush and membrane instruments, and surgical tamponades. The company serves hospitals and eye surgery centers performing vitreoretinal surgery, cataract surgery, and corneal procedures including DMEK.

DORC monetizes through a hybrid capital-equipment-plus-recurring-consumables model: one-time EVA NEXUS system placements generate ongoing per-procedure consumable purchases, with surgical dyes alone demonstrating multi-million-procedure adoption (VisionBlue in over 10 million cataract surgeries since launch, posterior dyes in over 3 million procedures). Pricing is quote-based and varies by market, region, volume, and contract terms; the company does not publish list prices. Distribution combines direct field sales operations in the United States (us.dorcglobal.com) and China (cn.dorcglobal.com) with a global distributor network for non-direct markets, supplemented by region-specific websites in English, French, German, Italian, and Spanish. The company maintains a strategic association with ZEISS Medical Technology, featuring ZEISS branding and cross-links to ZEISS ophthalmology specialties on its website. DORC operates sustainability and ESG programs evidenced by its 2024 EcoVadis Silver Partner certification and Green Web Foundation verification.

Name

D.O.R.C. Limited

Legal name

D.O.R.C. Limited

Website

https://dorc.eu

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

DORC (Dutch Ophthalmic Research Center) is a Netherlands-based medical device company that manufactures the EVA NEXUS ophthalmic surgical platform and proprietary consumables, instruments, and dyes used by hospitals and eye surgery centers worldwide for vitreoretinal, cataract, and corneal procedures.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades) (HLAHAJAJ)

akta.pro secondary industries

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Ophthalmic surgical equipment
• Vitreoretinal surgery devices
• Cataract surgery instruments
• Surgical dyes staining
• Ophthalmic surgical consumables

Headquarters

HQ city

Zuidland

HQ country

Netherlands

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Surgical Systems and Capital Equipment: DORC generates revenue through sale of capital surgical equipment including the EVA NEXUS surgical platform. These are one-time hardware sales with potential for aftermarket consumables and service revenue.
2. Surgical Consumables: Recurring revenue from consumable products including vitrectomy cutters, trocars, surgical dyes (VisionBlue, MEMBRANEBLUE-DUAL), surgical tamponades, surgical instruments, and accessories. Consumables are repurchased with each surgical procedure.
3. Surgical Instruments: Revenue from reusable and disposable surgical instruments including microforceps, microscissors, backflush instruments, membrane instruments, irrigation/aspiration handpieces, and surgical knives.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

D.O.R.C. Limited (Dutch Ophthalmic Research Center) manufactures and supplies ophthalmic surgical equipment, instruments, and consumables for vitreoretinal and cataract surgery. The product portfolio centers on the EVA NEXUS surgical platform and includes proprietary surgical dyes (VisionBlue, MEMBRANEBLUE-DUAL), high-speed vitrectomy cutters (TDC VELOCE), trocar cannula systems (EVA AVETA), single-use ophthalmic knives (SURGICON), and a range of reusable and disposable surgical instruments sold to hospitals and specialty eye surgery centers globally.

Product overview

DORC is a platform-plus-modules company offering ophthalmic surgical equipment, instruments, and consumables. The core platform is EVA NEXUS™, a surgical system that serves as the foundation for the product portfolio. Attached to this platform are modular consumables including TDC VELOCE™ (high-speed cutter), EVA AVETA™ (trocar cannula system), and various surgical consumables (vitrectomy cutters, laser probes, microinjection, diathermy). The instruments portfolio includes microforceps, microscissors, backflush instruments, and membrane instruments for vitreoretinal surgery, plus irrigation/aspiration and surgical knives for cataract procedures. Surgical liquids include VisionBlue® (trypan blue stain for cataract, 10M+ procedures), MEMBRANEBLUE-DUAL® (ILM/ERM staining, 3M+ procedures), and surgical tamponades. The company operates across three main surgical specialties: vitreoretinal, cataract, and other ophthalmic (including cornea instruments and DMEK).

Differentiator

Problem solved

Functional benefit

Brands

• EVA NEXUS™: Surgical system platform for ophthalmic surgery, including vitrectomy and cataract procedures
• TDC VELOCE™
• VisionBlue®
• MEMBRANEBLUE-DUAL®
• EVA AVETA™
• SURGICON

Products and services

• EVA NEXUS™ Surgical Platform Integrated capital surgical platform for ophthalmic surgery, sold to hospitals and specialty eye surgery centers performing vitreoretinal and cataract procedures. The platform serves as the foundation for the DORC consumables and instruments portfolio.
• VisionBlue® Trypan blue stain used for anterior capsulorrhexis staining during cataract surgery, sold as a sterile ophthalmic surgical liquid to hospitals and eye surgery centers.
• MEMBRANEBLUE-DUAL® Dual-action surgical dye for ILM and ERM staining during vitreoretinal membrane procedures, sold as a sterile ophthalmic surgical liquid to hospitals and specialty eye surgery centers.
• TDC VELOCE™ High-Speed Vitrectomy Cutter Next-generation high-speed vitrectomy cutter designed for use with the EVA NEXUS surgical platform in vitreoretinal procedures, sold to ophthalmic surgery centers.
• EVA AVETA™ Trocar Cannula System Trocar cannula system used for instrument access in vitreoretinal surgery, sold as part of the EVA NEXUS consumables portfolio to hospitals and eye surgery centers.
• SURGICON Ophthalmic Surgical Knives Single-use ophthalmic surgical knives for cataract procedures, sold to hospitals and eye clinics performing cataract surgery.
• DMEK Disposable Surgical Set Disposable surgical set designed for DMEK (Descemet Membrane Endothelial Keratoplasty) corneal procedures, sold to corneal surgery specialists and ophthalmic surgery centers.

Quantifiable outcome

• VisionBlue has been trusted for over 10 million cataract surgeries since launch
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• ZEISScoreStrategic or Co-development PartnerDORC operates in close association with ZEISS Medical Technology, linking to ZEISS medical technology products and social media channels. ZEISS is a major player in ophthalmic medical technology, and DORC positions itself under the ZEISS umbrella for ophthalmology solutions. DORC's website prominently features ZEISS branding and links to ZEISS Medical Technology specialities page for ophthalmology.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Others

• Heidelberg Engineering: Heidelberg Engineering is a specialist in ophthalmic diagnostic imaging (Spectralis OCT, HRT) rather than surgical devices, but its equipment is widely used in the same retinal care workflows where DORC's vitreoretinal consumables are deployed. It is an adjacent enabling technology peer rather than a direct competitor.

Emerging players

• IRIDEX Corporation: IRIDEX manufactures ophthalmic laser systems and laser probes used in retinal photocoagulation, overlapping with DORC's laser probe consumables in vitreoretinal surgery. It is a smaller, focused peer competing on the laser probe side of DORC's consumables portfolio.
• Hoya Corporation (Surgical Division): Hoya's surgical division produces intraocular lenses and surgical instruments used in cataract surgery. While Hoya is primarily known for IOLs, its surgical line competes for the same ophthalmic OR budgets and surgical workflow integration as DORC.
• Topcon Healthcare: Topcon is a Japanese ophthalmic device manufacturer with surgical microscope and diagnostic imaging offerings that intersect DORC's surgical workflow. While Topcon is stronger in diagnostics than in vitreoretinal consumables, it competes for the same OR capital budgets and integrated-OR positioning as DORC.
• Nidek: Nidek manufactures ophthalmic surgical and diagnostic equipment including phaco and vitrectomy systems. It is a smaller, Japan-headquartered peer that competes for capital equipment placements in cataract and vitreoretinal surgery with overlapping but narrower product depth than DORC.
• Geuder AG: Geuder is a German manufacturer of ophthalmic surgical instruments and devices used in vitreoretinal and cataract surgery. It is a comparable European specialty player competing with DORC in surgical instruments and consumables with similar scale and focus.

Broad incumbents

• Alcon: Alcon is the world's largest ophthalmic surgical device company, offering competing phaco and vitrectomy platforms, intraocular lenses, and surgical consumables. It is a broad incumbent that competes with DORC across both cataract and vitreoretinal workflows, but with a much larger portfolio spanning contact lenses, pharmaceuticals, and equipment.
• Carl Zeiss Meditec: Carl Zeiss Meditec is DORC's named strategic partner and the dominant manufacturer of ophthalmic surgical microscopes and intraoperative OCT. ZEISS-branded elements on DORC's site suggest a deep commercial or ownership relationship. ZEISS competes in adjacent ophthalmic visualization and is increasingly integrated into the same surgical workflows where DORC's consumables are used.
• Johnson & Johnson Vision: Johnson & Johnson Vision (operating TECNIS IOLs and the VERITAS phaco system) is a broad incumbent in cataract surgery. It competes directly with DORC's cataract consumables, phaco handpieces, and VisionBlue dye at high-volume cataract centers globally.
• Bausch + Lomb: Bausch + Lomb (a Bausch Health operating company) offers the Stellaris Elite vision enhancement system and a full consumables line for cataract and vitreoretinal surgery. It directly competes with DORC's EVA NEXUS platform and surgical dyes in the same surgical settings, with broader portfolio breadth across contact lenses and pharmaceuticals.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@dorcglobal
• Facebookfacebook.com/DORC-Dutch-Ophthalmic-Research-Center-102690838041999
• LinkedInlinkedin.com/company/d-o-r-c-limited

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about D.O.R.C. Limited